RFC: A Protein Essential for DNA Replication (P10289)

Target Name: Replication factor C

NCBI ID: P10289

Replication factor C

Other Name(s): None

RFC: A Protein Essential for DNA Replication

Replication factor C (RFC) is a protein that plays a crucial role in DNA replication in all living organisms. It is a key component of the replication complex, which is a set of proteins that work together to ensure the accurate replication of DNA in the cell. RFC is vital for the efficient and reliable DNA replication process, and it has been implicated in various diseases, including cancer. As a result, it has become an attractive drug target for researchers to explore for new treatments.

The replication complex is composed of several proteins, including RFC, which plays a vital role in the regulation of DNA replication. RFC helps to ensure that the DNA double helix is 鈥嬧?媟eplicated in the correct order, and that the copies of each gene are accurate copies . It does this by using a unique set of three proteins, called the TORC ternary complex, to check the accuracy of the DNA replication process.

One of the critical functions of RFC is its role in the regulation of the timing of DNA replication. RFC helps to ensure that the replication process occurs at the appropriate time, so that the new copies of the DNA can be synthesized at the right time to maintain the genetic integrity of the cell. It does this by playing a key role in the regulation of the activity of the DNA replication complex.

Another function of RFC is its role in the regulation of the quality of the DNA replicas. RFC uses a unique set of proteins called the SIRT1-RFC complex to ensure that the copies of each gene are accurate and compatible with the original DNA template. This helps to prevent errors that could lead to genetic mutations, which can lead to diseases such as cancer.

In addition to its role in DNA replication, RFC has also been implicated in the regulation of various cellular processes, including cell division, apoptosis, and inflammation. It is thought to play a key role in the regulation of cell division, by ensuring that the The correct number of chromosomes are replicated in each cell. It is also involved in the regulation of apoptosis, by ensuring that the DNA replication process is completed correctly before the cell undergoes apoptosis.

Due to its involvement in so many cellular processes, RFC has become an attractive drug target for researchers to explore for new treatments. Many researchers are currently working on developing drugs that can inhibit the activity of RFC, in order to treat various diseases. These drugs can include small molecules, such as inhibitors of the SIRT1-RFC complex, as well as antibodies that target RFC directly.

In addition to its potential as a drug, RFC is also an attractive biomarker for certain diseases. Its involvement in the regulation of DNA replication makes it an attractive marker for diseases that are characterized by DNA replication errors, such as cancer. In addition, RFC's role in the regulation of cellular processes makes it an attractive marker for diseases that are characterized by inflammation, such as autoimmune diseases.

In conclusion, Replication factor C (RFC) is a protein that plays a crucial role in the regulation of DNA replication in all living organisms. Its involvement in the replication complex and its role in the regulation of various cellular processes make it an attractive drug target for researchers to explore for new treatments. As a result, the development of drugs that can inhibit the activity of RFC is a promising area of 鈥嬧?媟esearch, with potential to improve the lives of many people.

Protein Name: Replication Factor C

The "Replication factor C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Replication factor C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets